ELISHBA SINHA: Open Payments
NPI 1588118285 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 2 payments from 2 companies in 2025. Trend: 2023 $428 · 2024 $148 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $135 |
| Grifols USA, LLC | 1 | $116 |
Products named: AUSTEDO XR, Prolastin-C Liquid.
Industry payments across TX — which companies pay providers there.
